Detalles de la búsqueda
1.
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Alcohol Clin Exp Res
; 44(7): 1431-1443, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32363592
2.
Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
Handb Exp Pharmacol
; 258: 443-462, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628604
3.
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
Alcohol Clin Exp Res
; 43(1): 158-169, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30403402
4.
Advances in Pharmacotherapy Development: Human Clinical Studies.
Handb Exp Pharmacol
; 248: 579-613, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29294197
5.
Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development.
Alcohol Clin Exp Res
; 40(7): 1368-79, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184259
6.
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Subst Abus
; 37(2): 286-98, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928397
7.
Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
Alcohol Clin Exp Res
; 44(1): 23-35, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31803968
8.
Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
Alcohol Clin Exp Res
; 38(5): 1196-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24689461
9.
Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs.
Alcohol Clin Exp Res
; 38(1): 27-32, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889161
10.
Posttreatment low-risk drinking as a predictor of future drinking and problem outcomes among individuals with alcohol use disorders.
Alcohol Clin Exp Res
; 37 Suppl 1: E373-80, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22827502
11.
The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies.
Alcohol Clin Exp Res
; 37(12): 2128-37, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889231
12.
A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.
Alcohol Clin Exp Res
; 36(3): 406-16, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21950727
13.
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
Alcohol Clin Exp Res
; 36(8): 1421-30, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22324516
14.
Medications development to treat alcohol dependence: a vision for the next decade.
Addict Biol
; 17(3): 513-27, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22458728
15.
Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.
Alcohol Clin Exp Res
; 34(12): 2022-34, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20659066
16.
Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment.
Alcohol Clin Exp Res
; 39(4): 579-84, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25833016
17.
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
JAMA Psychiatry
; 76(4): 374-381, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865232
18.
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.
Neuropsychopharmacology
; 42(5): 1012-1023, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658483
19.
An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder.
Contemp Clin Trials
; 50: 178-85, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27521807
20.
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
Drug Alcohol Depend
; 158: 1-7, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26652899